Skip to content Skip to footer

Recombinant 2019-nCoV Guanine-N7_meth (N-6His)

Recombinant 2019-nCoV Guanine-N7 methyltransferase is produced by our E.coli expression system and the target gene encoding Ala1-Gln527 is expressed with a 6His tag at the N-terminus.

Description

Reference ESCIT003
Size 50ug
Molecular Weight 62.9 KDa
Purity >85% by SDS-PAGE.
Endotoxin
Biological Activity

Other names: SARS-CoV 2 nsp14; SARS-CoV 2 ExoN; Guanine-N7 methyltransferase

 

Redissolve:

 

Storage: Store at ≤-70°C, stable for 6 months after receipt.
Store at ≤-70°C, stable for 3 months under sterile conditions after opening.
Please minimize freeze-thaw cycles.

 

Shipping Condition: Dry ice/polar packs.

 

Background: The nonstructural protein (nsp) 14 of SARS-CoV 2 was identified as a cap (guanine-N7)-methyltransferase (N7-MTase). Nsp14 of coronaviruses two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3′ to 5′ direction and a N7-guanine methyltransferase activity. It may be involved in the proof-reading ability during the viral RNA rESCIlication and transcription. GTP, dGTP as well as cap analogs GpppG, GpppA and m7GpppG could be methylated by nsp14.